Pulmonary embolism in a 30 year-old man with chronic hepatitis C during therapy with pegylated interferon-α and ribavirin

被引：0
|
作者：
Elikowski, Waldemar [1 ]
Malek, Malgorzata [1 ]
Kurosz, Jolanta [2 ]
Bereszynska, Iwona [3 ]
Marszalek, Andrzej [4 ]
Zawilska, Krystyna [5 ]
Mozer-Lisewska, Iwona [4 ,6 ]
机构：
[1] Szpital J Strusia, Oddzial Chorob Wewnetrznych, PL-61285 Poznan, Poland
[2] Szpital J Strusia, Pracownia Hemostazy, PL-61285 Poznan, Poland
[3] ZOZ Poznan Stare Miasto, Poradnia Chorob Watroby, Poznan, Poland
[4] Szpital J Strusia, Oddzial Chorob Zakaznych, PL-61285 Poznan, Poland
[5] Szpital J Strusia, Oddzial Chorob Wewnetrznych & Hematol, PL-61285 Poznan, Poland
[6] Uniwersytet Med, Katedra & Klin Chorob Zakaznych, Poznan, Poland
来源：
KARDIOLOGIA POLSKA | 2010年 / 68卷 / 11期
关键词：
pulmonary embolism; interferon-alpha; ribavirin; chronic hepatitis C; VENOUS THROMBOEMBOLISM; CUTANEOUS NECROSIS; PLUS RIBAVIRIN; PATIENT; COMBINATION; INJECTION; FIBROSIS; PROTEIN; VIRUS; RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The authors described a case of a 30 year-old man with chronic hepatitis C (G1,S1) complicated by pulmonary embolism (PE), preceded by symptoms of respiratory system infection, which occurred after 6 months of combination therapy with pegylated interferon-a and ribavirin. Right sided nonbacterial thrombotic endocarditis as a source of segmental/subsegmental PE was found. Hemostatic work up showed increased activated protein C resistance, elevated factor VIII activity and fibrinogen concentration as well as hyperhomocysteinaemia (all these disturbances returned to normal 3-6 months later). The patient's clinical status improved during anticoagulation therapy. Antiviral treatment was not continued as virological response was achieved.
引用
收藏
页码：1261 / 1265
页数：5
相关论文
共 50 条
  • [1] Tubo-ovarian abscess during therapy of chronic hepatitis C with pegylated interferon and ribavirin
    Inglot, Malgorzata
    Szymczak, Aleksandra
    Fleischer-Stepniewska, Katarzyna
    Fleischer, Malgorzata
    Staszek-Zurowska, Bogumila
    Gladysz, Andrzej
    NEUROENDOCRINOLOGY LETTERS, 2011, 32 (01) : 1 - 3
  • [2] Interstitial pneumonitis during combination therapy with interferon-α and ribavirin in a patient with chronic hepatitis C
    Rothfuss, KS
    Bode, JC
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2002, 40 (09): : 807 - 810
  • [3] THYROID FUNCTION OUTCOMES AFTER PEGYLATED INTERFERON-α AND RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C
    Tran, Huy A.
    Reeves, Glenn E. M.
    Ianna, Elizabeth A.
    Leembruggen, Nadine
    ENDOCRINE PRACTICE, 2010, 16 (06) : 934 - 939
  • [4] Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus
    Foster, GR
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (05) : 685 - 691
  • [5] Leukocyte interferon-α and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon
    Adinolfi, Luigi E.
    Durante-Mangoni, Emanuele
    Salzillo, Marta
    Marrone, Aldo
    Tripodi, Marie-Francoise
    Restivo, Luciano
    Merola, Antonietta
    Zampino, Rosa
    Ruggiero, Giuseppe
    INTERNAL AND EMERGENCY MEDICINE, 2009, 4 (06) : 485 - 490
  • [6] Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea
    Cho, Hyun Chin
    Gwak, Geum-Youn
    Paik, Yong Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Yoo, Byung Chul
    Paik, Seung Woon
    GUT AND LIVER, 2013, 7 (05) : 585 - 593
  • [7] Psychiatric side effects of pegylated interferon-α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta-analysis
    Davoodi, Lotfollah
    Masoum, Babak
    Moosazadeh, Mahmood
    Jafarpour, Hamed
    Haghshenas, Mohammad Reza
    Mousavi, Tahoora
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (02) : 971 - 978
  • [8] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [9] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [10] Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C
    Karino, Y.
    Ozeki, I.
    Hige, S.
    Kimura, M.
    Arakawa, T.
    Nakajima, T.
    Kuwata, Y.
    Sato, T.
    Ohmura, T.
    Toyota, J.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (05) : 341 - 347
12345